219 search results for: burden of disease

ESPGHAN 2024 | Clinical Management <b>of</b> EoE in Adolescents to Adulthood
Gastroenterology
ESPGHAN 2024 | Clinical Management of EoE in Adolescents to Adulthood
expert video

Prof. Salvatore Oliva discusses the latest treatment options for adolescents and adults with EoE and the importance of effective transition of care.

View more
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
Dermatology
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema

View more
Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid
Dermatology
Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid
expert video

Join Dr. Victoria Werth in exploring the clinical presentation of BP and how type 2 inflammation contributes to the development of disease signs and symptoms

View more
Atopic Dermatitis in Children: Not Just a Skin <b>Disease</b>
Dermatology
Atopic Dermatitis in Children: Not Just a Skin Disease
expert video

In this video of the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Mark Boguniewicz discusses the multidimensional and cumulative disease burden of AD and its associated comorbidities in children. Dr Boguniewicz also highlights the burden experienced by caregivers of children with AD

View more
The PEDISTAD Survey: Assessing the <b>Burden</b> <b>of</b> Atopic Dermatitis in the Global Pediatric Population
Dermatology
The PEDISTAD Survey: Assessing the Burden of Atopic Dermatitis in the Global Pediatric Population
Infographic

An interactive tool used to explore the global burden of atopic dermatitis in children and adolescents.

View more
How Biologic Therapy May Lead to Disease Modification in Infants and Children with Atopic Dermatitis
On Demand
How Biologic Therapy May Lead to Disease Modification in Infants and Children with Atopic Dermatitis

The underlying pathophysiology of atopic dermatitis (AD) is driven by dysregulation of type 2 immunity that contributes to skin barrier dysfunction. AD typically develops very early in life and children with AD often develop other atopic conditions such as food allergy, asthma, and allergic rhinitis in a progression called the atopic march. Early treatment may help reduce the atopic march and other comorbidities to lessen the lifetime burden created by these diseases. There may even be a window of opportunity for disease modification.

Most <b>Burden</b>some Symptoms Rated by PN Patients
Dermatology
Most Burdensome Symptoms Rated by PN Patients
expert video

Dr. Chovatiya discusses the impact of pruritus on patients with PN.

View more
Children and EoE: More Than Just Being a Picky Eater
Gastroenterology
Children and EoE: More Than Just Being a Picky Eater
expert video

Join Prof. Alexandra Papadopoulou as she reviews the multifaceted burden of children with EoE.

View more
The <b>Burden</b> in Patients with CRSwNP and Coexisting Asthma
Pulmonology
The Burden in Patients with CRSwNP and Coexisting Asthma
expert video

This video supports improved clinical awareness and encourages comprehensive care strategies for patients living with both CRSwNP and asthma.

View more
EoE Quest: Navigating the Patient Experience
Gastroenterology
EoE Quest: Navigating the Patient Experience
interactivity

Want to test your EoE knowledge while learning more about the patient journey? Try EoE Quest, an engaging and educational interactive experience.

View more
Itch in Prurigo Nodularis
Dermatology
Itch in Prurigo Nodularis
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Brian Kim discuss the burdensome itch in prurigo nodularis, the multifactorial etiology of the disease, and the multiple pathological factors that contribute to chronic itch and skin inflammation in PN.

View more
EADV 2025
On Demand
Bullous Pemphigoid: Insights and Innovations

Experience this engaging presentation by Dr. Donna Culton, Prof. Dédée Murrell, and Prof. Ulrike Raap, who highlight the heterogeneous clinical presentations of BP and its burden, delve beneath the surface into how autoimmunity and predominantly type 2 inflammation mediate the disease, and explore the evolving toolbox of current approaches in BP management.